(Q37627336)

21 August 2017

1 reference

title

Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin (English)

1 reference

21 August 2017

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

D T Dieterich

1

1 reference

PubMed ID

19889142

21 August 2017

M Rizzetto

series ordinal

2

1 reference

PubMed ID

19889142

21 August 2017

M P Manns

series ordinal

3

1 reference

21 August 2017

1 December 2009

1 reference

Journal of Viral Hepatitis

21 August 2017

1 reference

21 August 2017

16

1 reference

21 August 2017

12

1 reference

21 August 2017

833-843

1 reference

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01218.X

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01218.X

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01218.X

Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon-alpha2b: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01218.X

10.1111/J.1365-2893.2009.01218.X

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19889142